These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6435673

  • 1. The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
    Lasslo A, White JG.
    Biochim Biophys Acta; 1984 Oct 17; 777(1):37-40. PubMed ID: 6435673
    [Abstract] [Full Text] [Related]

  • 2. Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agent.
    Gollamudi R, Dillingham EO, Bond SE, Lyman BA.
    Biochem Biophys Res Commun; 1991 Jun 14; 177(2):888-93. PubMed ID: 2049109
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
    Lyman BA, Bond SE, Dillingham EO, Lawrence WH, Gollamudi R.
    Res Commun Chem Pathol Pharmacol; 1992 Dec 14; 78(3):279-88. PubMed ID: 1475529
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D, Dillingham EO, Lyman BA, Zheng X, Bond SE, Salgia SR, Gollamudi R.
    Prostaglandins Leukot Essent Fatty Acids; 1995 May 14; 52(5):309-18. PubMed ID: 7630919
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
    Han G, Bannerman D, Handa RK, Dillingham EO, Lawrence WH, Gollamudi R.
    Gen Pharmacol; 1997 Apr 14; 28(4):617-21. PubMed ID: 9147034
    [Abstract] [Full Text] [Related]

  • 6. Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.
    Handa RK, Dillingham EO, Gollamudi R.
    Life Sci; 1995 Apr 14; 57(10):983-8. PubMed ID: 7643723
    [Abstract] [Full Text] [Related]

  • 7. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G, Di Gregorio M, Ridolfi D, D'Alonzo L, Izzi L.
    Quad Sclavo Diagn; 1987 Sep 14; 23(3):331-40. PubMed ID: 3140287
    [Abstract] [Full Text] [Related]

  • 8. Enantioselective antiplatelet actions of nipecotamides.
    Gollamudi R, Feng Z, Dillingham EO, Bond SE, Han G, Salgia S.
    Thromb Res; 1993 Feb 15; 69(4):361-7. PubMed ID: 8470057
    [Abstract] [Full Text] [Related]

  • 9. Preliminary in vivo studies on the platelet aggregation inhibitory activity of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide in beagle dogs.
    Lawrence WH, Gollamudi R, Dillingham EO, Carter-Burks G, Tisdelle PA, Lasslo A.
    J Pharm Sci; 1988 May 15; 77(5):464-5. PubMed ID: 3411473
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of thrombus formation in vivo by novel antiplatelet agent.
    Marzec UM, Kelly AB, Hanson SR, Lasslo A, Harker LA.
    Arteriosclerosis; 1990 May 15; 10(3):367-71. PubMed ID: 2140503
    [Abstract] [Full Text] [Related]

  • 11. Subcellular localization of vasopressin-like material in platelets.
    Chesney CM, Crofton JT, Pifer DD, Brooks DP, Huch KM, Share L.
    J Lab Clin Med; 1985 Sep 15; 106(3):314-8. PubMed ID: 3928782
    [Abstract] [Full Text] [Related]

  • 12. Vernolepin: an antiplatelet compound of natural origin.
    Laekeman GM, De Clerck F, Vlietinck AJ, Herman AG.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct 15; 331(1):108-13. PubMed ID: 3934564
    [Abstract] [Full Text] [Related]

  • 13. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
    Egger M, Donath E, Spangenberg P, Bimmler M, Glaser R, Till U.
    Biochim Biophys Acta; 1988 Dec 09; 972(3):265-76. PubMed ID: 3143424
    [Abstract] [Full Text] [Related]

  • 14. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
    Yanagisawa H, Wada O.
    Ind Health; 1985 Dec 09; 23(4):255-68. PubMed ID: 3938784
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of heparin on platelet aggregation in vitro].
    Róka L, Isert D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Dec 09; 111(6):735-49. PubMed ID: 6083949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fish oil: a potent inhibitor of platelet adhesiveness.
    Li XL, Steiner M.
    Blood; 1990 Sep 01; 76(5):938-45. PubMed ID: 2118400
    [Abstract] [Full Text] [Related]

  • 18. Platelet storage pool deficiency of alpha and delta granules.
    Biddle DA, Neto TG, Nguyen AN.
    Arch Pathol Lab Med; 2001 Aug 01; 125(8):1125-6. PubMed ID: 11473478
    [No Abstract] [Full Text] [Related]

  • 19. The role of phosphorylation/dephosphorylation reactions in the function of blood platelets.
    Gerrard JM, Beattie LL, Israels SJ, Park J.
    Agents Actions Suppl; 1986 Aug 01; 20():129-45. PubMed ID: 3101441
    [No Abstract] [Full Text] [Related]

  • 20. A variant form of thrombasthenia.
    Tarantino MD, Corrigan JJ, Glasser L, Payne CM, Jeter MA.
    Am J Dis Child; 1991 Sep 01; 145(9):1053-7. PubMed ID: 1908636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.